Compugen Ltd. (CGEN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Compugen Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.660 -- 00:00:04.762 Ladies and gentlemen, thank you for joining us today. 00:00:04.762 -- 00:00:09.726 Welcome to Compugen's second quarter 2026 results conference call. 00:00:09.726 -- 00:00:13.128 At this time, all participants are in list and only mode. 00:00:13.128 -- 00:00:18.732 An audio webcast of this call is available in the investor section of Compugen's website 00:00:18.732 -- 00:00:22.013 at www.cgen.com. 00:00:22.154 -- 00:00:25.236 As a reminder, today's call is being recorded. 00:00:25.236 -- 00:00:30.349 I will now hand the call over to Lindsay Trickett, Head of Investor Relations and Corporate 00:00:30.349 -- 00:00:34.692 Communications to begin. Lindsay, please go ahead. 00:00:34.692 -- 00:00:39.015 Thank you, Operator. Good morning and good afternoon, everyone, and welcome to CONFIGEN's 00:00:39.015 -- 00:00:42.797 second quarter 2026 Financial Results Conference Call. 00:00:42.797 -- 00:00:48.260 With us today are Dr. Eran Ophir, President and Chief Executive Officer, and David Silberman, 00:00:48.260 -- 00:00:53.283 Chief Financial Officer. Dr. Michelle Mahler, Chief Medical Officer, will join us for 00:00:53.283 -- 00:00:57.947 the Q&A portion of the call. Before we begin, I'd like to remind you that during this 00:00:57.947 -- 00:01:02.770 call, the company may make projections or forward-looking statements regarding future 00:01:02.770 -- 00:01:07.193 events, business outlook, development efforts, and their potential outcomes. 00:01:07.193 -- 00:01:12.516 The company's discovery platform, anticipated progress and plans, results and timelines 00:01:12.516 -- 00:01:17.599 for our programs, including disclosure of clinical data, financial and accounting-related 00:01:17.599 -- 00:01:22.421 matters, as well as statements regarding ...